Why Dr. Mark Holterman Advocates For Stem Cell Therapy And Regenerative Medicine

Dr. Mark Holterman is a medical doctor and an entrepreneur. His specialty is pediatric surgery and he has 30 years of experience. He earned his undergraduate in biology, graduating in 1980 from Yale University. At the University of Virginia he earned both his medical degree and his Ph.D. in medicine and immunology in 1988 (Ideamensch).

It was at the University of Virgina that he completed his residency at Seattle Children’s Hospital he performed his fellowship. During this time he also taught pediatric surgery to students at the nearby University of Washington. Over the course of his professional career he has also taught at the University of Illinois, Chicago, and at the University of Illinois College of Medicine, Peoria.

From 2000 to 2012, Dr. Mark Holterman practiced medicine at the Rush University Medical Center in Chicago, Illinois. He now is the chief executive officer of a company he founded called Mariam Global Health. Through this company he invests in companies around the world that his research shows are excellent opportunities. He also offers business management services. His focus is on people who are working on a product or service that will have a huge impact on people’s lives in regards to global health.


Extensive Research

For many years Dr. Mark Holterman has been advocating for stem cell therapy as well as regenerative medicine. He says that ethically sourced fetal stem cells can be researched to provide cures for many diseases. When talking about regenerative medicine, Dr. Mark Holterman says that restoring organs and tissues to full functionality can be very much a preferred alternative to waiting for an organ donation. He says that sometimes these organs and tissue won’t respond to conventional therapies. In that case, tissue engineering and advancements in gene editing make it possible cure the patient.

Dr. Mark Holterman is a member of several healthcare industry organizations. Among these are the Alliance for the Advancement of Cellular Therapies, the American Academy of Pediatrics, Surgical Sections, The American Diabetes Association, and the Pacific Association of Pediatric Surgeons among others. His bedside manner includes his ability to speak both English and Spanish fluently.